This report describes an attempt to define the factors which incite secondary bacterial pneumonias. Groups of mice were given bacteria intraperitoneally and, at various intervals, Newcastle disease virus intravenously. There was an increase in the number of deaths and in the rates of death in these groups, when compared with a control group which was given only bacteria. These results were obtained with Streptococcus pnewnoniae (Diplococcus pneumoniae), Pseudomonas Several investigators postulate a synergism between viruses which cause certain diseases, such as measles, influenza, and smallpox, and bacteria which cause secondary infections. Cumming (4) postulates a synergism between betahemolytic streptococci and these viruses. He notes that the streptococcal carrier rate is essentially coincident with fatalities from these viral diseases, which are usually not fatal if uncomplicated. He also observed that the susceptibility of streptococcal carriers to viral infections is greater than that of noncarriers. A portion of the tracheal and bronchial epithelium is desquamated in patients with secondary bacterial pneumonias which follow influenza-virus infections (5).
Bacteria were selected for their varied characteristics and clinical importance.
MATERIALS AND METHODS
Animals. Female Swiss mice, strain DUB/ICR, 3 to 3.5 weeks old and weighing 10 to 12 g each (Flow Laboratories, Inc., Dublin, Va.), were used.
Viruses. Newcastle disease virus strain Bi was harvested in the allantoic fluid (NDV-AF) of 11-dayold chick embryos after incubation at 37 C for 2 days, titered in cultures of chick embryo fibroblasts, and stored at -70 C in small portions; the titer was 2.5 X 107 plaque-forming units/mi. A 0.4-ml quantity was inoculated intravenously (iv) into mice. Vesicular stomatitis virus Indiana strain (VSV) was propagated in cultures of chick embryo fibroblasts at 37 C, titered in cultures of mouse fibroblasts (L 929), and stored at -70 C in small portions; the titer was 10"-5 tissue culture infectious dose (TCID5o)/ml (7) .
Interferon. Mice were given 0.4-ml quantities of NDV-AF iv. After 10 hr, they were bled and the serum was collected. Virus was removed from the serum by centrifugation at 105,000 X g for 90 min. The titer of interferon in the mouse serum (MSI) was determined by using tube cultures of mouse fibroblasts (L929) challenged with 90 TCID5o of VSV. The titer was defined as the reciprocal of the serum dilution which inhibited 50%0 of the cytopatic effect (14) ; the titer was 6.25 X 104 units of interferon per ml. A 0.2-mi quantity was inoculated iv into mice.
Bacteria. S. pneumoniae type 22 strain S 6, S.
NDV-ENHANCEMENT OF MOUSE INFECTIONS
time of inoculation into mice by preparing 3.5%, rabbit blood-agar pour plates with dilutions of the inoculum in 0.9% NaCl and counting the number of colonies after incubation of the plates at 37 C for 48 hr. Pseudomonas aeruginosa strain RH 815 (ATCC 10145) and Salmonella enteritidis ser. typhimurium strain RH 2748 (ATCC 13311) were also stored in skimmed milk. The viable counts of these organisms were determined by preparing blood-agar base (Difco 0045) pour plates and counting the number of colonies after incubation at 30 C for 48 hr.
A 0.5-ml quantity of a bacterial suspension in 0.9% NaCl was inoculated intraperitoneally (ip) into mice.
Experiments. Experiments were performed to determine (i) the effect of NDV on an experimentally induced bacterial infection and (ii) the effects of various time intervals between the inoculations of the virus and the bacteria into mice.
(A) NDV-AF was inoculated iv into each of eight mice. Six hours later, each mouse was given ip 600 CFU of S. pneumoniae type 22. Only S. pneumoniae was inoculated into control mice. This experiment was repeated with inocula as low as 3 In all experiments, mice were autopsied after death. The appearance of the lungs was noted, and the cardiac blood and peritoneal fluid were streaked on a rabbit blood-agar plate on which an optochin or bacitracin disc, respectively, was placed when S. Total inoculations 8 8 pneumoniae and S. pyogenes were used or on a bloodagar base plate when P. aeruginosa and S. enteritidis were used. Results (days until death after bacterial challenge) were treated with the Kruskal-Wallis one-way analysis of variance by ranks. Each test group was then compared with the appropriate control group by using the Mann-Whitney two-sample rank test.
RESULTS
In the experiments performed to determine (i) the effect of NDV on an experimentally induced bacterial infection and (ii) the effects of various time intervals between the inoculations of the virus and bacteria into mice, the mice treated with both NDV significant difference between the groups in C and the Kruskal-Wallis test indicates no significant differences among the groups in D. The lungs of all dead mice were consolidated. The cardiac blood and the peritoneal fluid contained the viable bacteria inoculated. DISCUSSION NDV appears to increase the rate of death of mice from S. pneumoniae, P. aeruginosa, and S. enteritidis infections when NDV is inoculated into mice within 24 hr of exposure to these (15) searched for the factors which protect mice from bacterial infection and found that interferon had no significant effect.
These results neither prove nor disprove that interferon is involved, since the MSI is diluted considerably after injection and is rapidly removed from the blood (3). The role of interferon in the phenomenon can be established by using purified interferon when it becomes available.
These laboratory animal studies may lead to a better understanding of how secondary bacterial pneumonias following influenza-virus infections swiftly evolve to terminal disease and how chronic or acute bacterial infections evolve to endotoxic shock.
Certainly, these observations warrant further investigation of the effects of viruses, interferons, and other inducers of interferons on bacterial infections, and on infections of other kinds of microorganisms as well.
